Shares of Contract Research Organizations including Icon plc (ICLR), Fortrea (FTRE) and Charles River Labs (CRL) are trading lower after peer Medpace (MEDP) reported earnings last night and spoke to “a higher level cancellations overall” in Q4. Shares of Medpace are down $66.26, or 12%, to $464.09 in morning trading.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
- Icon price target raised to $183 from $172 at TD Cowen
- ICON’s Role in Zealand Pharma’s Petrelintide Kidney Study: What Trial Completion Means for Investors
- Icon price target lowered to $217 from $220 at Baird
- Icon price target lowered to $216 from $225 at Mizuho
- Icon downgraded to Hold from Buy at Truist